|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.00 INR | -7.89% |
|
-1.82% | -0.24% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 91.84 |
| Change | - |
| Enterprise Value (EV) 1 | 61.1 |
| Change | - |
| P/E | 21.2x |
| PBR | 1.04x |
| PEG | -1.1x |
| Capitalization / Revenue | 1.12x |
| EV / Revenue | 0.74x |
| EV / EBITDA | 7.34x |
| EV / EBIT | 16x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | 1.896 |
| Distribution rate | - |
| Net sales 1 | 82.35 |
| EBITDA 1 | 8.319 |
| EBIT 1 | 3.821 |
| Net income 1 | 3.947 |
| Net Debt 1 | -30.75 |
| Reference price 2 | 40.24 |
| Nbr of stocks (in thousands) | 2,282 |
| Announcement Date | 26/8/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.01M | |
| -168.11x | 13.93x | -190.67x | -.--% | 40B | |
| 19.93x | 1.91x | 11.03x | 1.02% | 23.53B | |
| 16.76x | 1.32x | 7.47x | 5.19% | 7.17B | |
| 352.56x | - | - | - | 5.41B | |
| 54.39x | 9.61x | 33.74x | 0.85% | 2.9B | |
| -22.52x | - | - | - | 2B | |
| -34.01x | - | - | -.--% | 1.97B | |
| 31.86x | 1.14x | 9.5x | 0.79% | 1.83B | |
| 12.41x | 1.3x | 5.09x | 6.1% | 1.65B | |
| Average | 29.25x | 4.87x | -20.64x | 1.99% | 8.65B | |
| Weighted average by Cap. | -47.48x | 8.35x | -93.30x | 0.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
